Evaluation of the effects of a novel carbon monoxide releasing molecule (CORM-3) in an in vitro model of cardiovascular inflammation by Vannacci, Alfredo et al.
Infl amm. res. 55, Supplement 1 (2006) S05–S06
1023-3830/06/01S05-02
DOI 10.1007/s00011-005-0015-3
Infl ammation Research
© Birkhäuser Verlag, Basel, 2006
1. Histamine in allergy, infl ammation, tissue gowth and repair
Evaluation of the effects of a novel carbon monoxide releasing 
molecule (CORM-3) in an in vitro model of cardiovascular 
infl ammation.
A. Vannacci1, C. Marzocca1, L. Giannini1, L. Mazzetti1, S. Franchi-Micheli1, P. Failli1, E. Masini1, R. Motterlini2 
and P. F. Mannaioni1
1
  Department of Preclinical and Clinical Pharmacology, University of Florence, Viale G. Pieraccini 6, 50139, Florence, Italy, 
Fax: ++39 0 554271280, e-mail: pierfrancesco.mannaioni@unifi .it, Department of Preclinical and Clinical Pharmacology; University of Florence, 
Italy
2
 Vascular Biology Unit, Department of Surgical Research, Northwick Park Institute for Medical Research, Harrow, UK
Introduction
Heme oxygenase 1 (HO-1) is a stress-responsive enzyme that 
is active during infl ammatory reactions. Expression of HO-1 
regulates infl ammatory and immune responses, such as those 
involved in cardiac anaphylaxis [1], in allergic reactions [2] 
and in the rejection of transplanted organs [3]. Three prod-
ucts of HO-1 catalyzed heme breakdown can mediate these 
effects: CO, biliverdin and free iron (Fe2+). Among them, a 
relevant role could be played by CO, a gaseous mediator that 
has been shown to be highly protective in several disease 
models, mimicking the action of HO-1 [4].
Previous reports from our group showed that exogenous CO 
or water-insoluble CO-releasing molecules (CORMs) were 
able to mimic the anti-allergic and anti-anaphylactic effects 
of heme oxygenase in isolated guinea pig hearts [1], in guinea 
pig mast cells and in human basophils [2, 5], mainly through 
the activation of the soluble guanylyl cyclase. Because the 
available CORMs were not water soluble, Motterlini’s group 
synthesized new CO carriers, chemically modifi ed to allow 
solubility in water [6]. Among them, tricarbonylchloro(glyc
inate)ruthenium(II) (CORM-3) was chosen for the present 
study. The inactivated form of CORM-3 (iCORM), unable 
to release CO, was used as a negative control. The aim of 
the present study was to evaluate the effects of CORM-3 in 
a coincubation model of rat coronary endothelial cells with 
human neutrophils, activated with a chemotactic peptide.
Materials and methods
Rat coronary endothelial cells (EC) were cultured in a Petri dish at the 
density of 8,000–10,000 cell/cm2. About 50,000 human polimorphonu-
cleated neutrophilic granulocytes (PMN), isolated from healthy donors, 
were suspended in the supernatant of the EC cultures. PMN were then 
activated by means of the chemotactic peptide formyl-methionyl-leu-
cyl-phenylalanine (fMLP) 10 nM, in the presence or in the absence of 
CORM-3 (10 nM–100 µM). In some experiments, superoxide dismutase 
(SOD, 300 IU/ml) was also used in the place of CORM-3 to assess the 
involvement of superoxide anion generation in the PMN-induced activa-
tion of EC. The activation of PMN was assessed through fl ow cytometric 
evaluation of CD11b expression on the cell surface, while EC activation 
was measured assessing the membrane expression of the activation 
marker CD54.
Results and discussion
The expression of CD54 on EC membranes was increased 
after incubation with PMN stimulated by fMLP (Fig. 1A). 
CORM-3 reduced the activation of EC, while the inactivate 
form, (iCORM), unable to release CO, was ineffective (Fig. 
1B). PMN signifi cantly increased the production of ROS 
upon activation with fMLP (data not shown) and, consist-
ent with the hypothesis that superoxide anions play a role 
in endothelium activation, treatment of the cells with SOD 
mimicked the effects of CORM-3 (Fig. 1B). Finally, CORM-
3 also reduced the activation of human PMN, assessed as the 
membrane expression of CD11b (Fig. 2A). The inactivated 
form of CORM-3 (iCORM) and SOD were ineffective (Fig. 
2B). 
In summary, CORM-3 was highly effective at reduc-
ing PMN-induced CD54 expression on EC. The effect was Correspondence to: P. F. Mannaioni
S6 Infl amm. res. Supplement 1 (2006)
mediated by the release of CO, since the inactivated form of 
CORM-3 (iCORM) was completely ineffective. We can also 
suggest an involvement of superoxide anions, since the acti-
vation of EC was completely reversed by incubating the cells 
with SOD. CORM-3 also reduced the activation of PMN, 
as evidenced by decreased expression of CD11b on the cell 
membrane, while SOD was ineffective. The production of 
reactive oxygen species and the degranulation of PMN ap-
pear to be two parallel aspects of cell activation, and the 
scavenging role of SOD is apparent after CD11b expression 
has occurred.
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Fig. 1. The expression of CD54 
on endothelial cell (EC) mem-
branes was increased after 
incubation with neutrophils 
(PMN) stimulated by fMLP (A). 
CORM-3 reduced the activation 
of EC (A), while the inactivated 
form of the drug, iCORM, un-
able to release CO, was ineffec-
tive (B). Treatment of the cells 
with SOD mimicked the effects 
of CORM-3 (B). #p < 0.01 vs. 
basal; *p < 0.05 vs. EC + PMN 
+ fMLP.
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Fig. 2. CORM-3 reduced the 
activation of human PMN, as-
sessed as membrane expression 
of CD11b (A). The inactivated 
form of CORM-3 (iCORM) and 
SOD were ineffective (B). #p 
< 0.01 vs. basal; *p < 0.05 vs. 
PMN + fMLP.
